Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42

作者：

Uppendahl, Locke D. ^{[1
]}

Dahl, Carly M. ^{[2
]}

Miller, Jeffrey S. ^{[3
]}

Felices, Martin ^{[3
]}

Geller, Melissa A. ^{[1
]}

机构：

[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA

来源：

FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷

关键词：

natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;

D O I：

10.3389/fimmu.2017.01825

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.

引用

页数：15

共 50 条

[41] NK Cell-Based Immunotherapy for Hematological Malignancies
Sivori, Simona
Meazza, Raffaella
Quintarelli, Concetta
Carlomagno, Simona
Della Chiesa, Mariella
Falco, Michela
Moretta, Lorenzo
Locatelli, Franco
Pende, Daniela
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
[42] Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Hoke, Austin T. K.
Padget, Michelle R.
Fabian, Kellsye P.
Nandal, Anjali
Gallia, Gary L.
Bilusic, Marijo
Soon-Shiong, Patrick
Hodge, James W.
London Jr, Nyall R.
CANCER RESEARCH COMMUNICATIONS, 2021, 1 (03): : 127 - 139
[43] NK cell-based immunotherapy for malignant diseases
Cheng, Min
Chen, Yongyan
Xiao, Weihua
Sun, Rui
Tian, Zhigang
CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) : 230 - 252
[44] New frontiers in cell-based immunotherapy of cancer
D'Elios, Mario Milco
Del Prete, Gianfranco
Amedei, Amedeo
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (05) : 623 - 641
[45] Improving natural killer cell cancer immunotherapy
Berrien-Elliott, Melissa M.
Romee, Rizwan
Fehniger, Todd A.
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (06) : 671 - 680
[46] Dendritic cell-based glioma immunotherapy (Review)
Yamanaka, R
Yajima, N
Abe, T
Tsuchiya, N
Homma, J
Narita, M
Takahashi, M
Tanaka, R
INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (01) : 5 - 15
[47] Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells
Ferreira-Teixeira, Margarida
Paiva-Oliveira, Daniela
Parada, Belmiro
Alves, Vera
Sousa, Vitor
Chijioke, Obinna
Munz, Christian
Reis, Flavio
Rodrigues-Santos, Paulo
Gomes, Celia
BMC MEDICINE, 2016, 14
[48] Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells
Margarida Ferreira-Teixeira
Daniela Paiva-Oliveira
Belmiro Parada
Vera Alves
Vitor Sousa
Obinna Chijioke
Christian Münz
Flávio Reis
Paulo Rodrigues-Santos
Célia Gomes
BMC Medicine, 14
[49] Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy
Zhu, Huang
Lai, Yi-Shin
Li, Ye
Blum, Robert H.
Kaufman, Dan S.
STEM CELLS, 2018, 36 (02) : 134 - 145
[50] Role of natural killer cell function in dendritic cell-based vaccines
Woo, Christopher Y.
Clay, Timothy M.
Lyerly, H. Kim
Morse, Michael A.
Osada, Takuya
EXPERT REVIEW OF VACCINES, 2006, 5 (01) : 55 - 65

← 1 2 3 4 5 →